! "Parathyroid hormone restores bone mass for osteopenia in the
spontaneously hypertensive rat #$NSC87-2314-B-039-017 %&'(86/08/01~87/07/31 )*+,-. %&/0123456789:58;<= E-mail[email protected] > ? 19 @A
(spontaneously hypertensive rat, SHR)BCD /EFGHI 4 JBK-LMNOPQR HSTUHVWX 0Y4Y8 Z 16 [\/100g + ] (human parathyroid hormone, hPTH1-34)B^_ 14 -BL`a XbcdefghiB21 @jkl hPTH SHRBmnopq
Xrstu Wistar Kyoto (WKY rat) vwxByg0z{rIq|f}~q Bjbf hPTH JBmnopqX1 Bs~1 9def H1 ¡ B¢ 16 [\ hPTH J£xB ¤J¥j¦§¨©fªz«B hPTH¬®¯°B ±²j¦§B³´X µhf¶MNOP hPTH · X/¸B¹º»¼½f¾J¿e À7ÁÂÃiBhPTH J¿ ÄÅ®ÆÇ±²B)ÈÉÊc Ë ÌÍÎÏf Abstract
Daily subcutaneous injection of graded doses of 0, 4, 8, or 16Ðg / 100g hPTH 1-34 of 19-week-old male spontaneously hyperten- sive rat (SHR) of five rats in each group for 14 days were done. The 21-week-old SHR exhibited a significant lower metaphyseal trabecular bone volume osteopenia accompanied by poor trabecular architecture than in Wistar-Kyoto (WKY) rats were observed in the study. The preservation of trabecular bone volume in the PTH-treated rats was associated with an increase in number of osteoblasts, bone surface extent of osteoblasts, double labelled bone surface, mineral apposition rate and trabecular thickness. Trabecular number remained comparable to control. Measurements of resorption such as percent eroded surface and numbers of osteoclasts also remained comparable to control values. These dual effects increase the bone formation rate and in the absence of significant resorption, result in a net increase in bone mass. The above findings of histomorphometric data support the hypothesis that the PTH increase bone mass by specific effects on osteoblast activation and function.
Key word: Parathyroid hormone, osteo-porosis, spontaneous hypertensive rat, osteopenia, bone cell.
ÑY !" ? ÒÓ4ÔÕ+Ö×ØÙ 1990 Ú 2036ÚuB+Ö 65 Û°¬× 6% 20.5%Bܾ 123 Ý 517 Ý(1)f Þ}Bßqà1áâQ ! ã Bäåæ»çèf ßqà(osteoporosis)å>éêë ì í î B ¾ X (osteopenia)Bçïá (2)f1993 Ú ,-.ðñBòØÙ 2020 Ú ó4Ô ÕôõöÚ+ÖÞßqà÷® áø²BKÚùúøûÔü 1600 ýÙ (3)f¾Lz«Bßqàþ »·f (spontaneously hypertensive rat, SHR)
(Wistar-Kyoto WKY, rat)å ¾ Wistar ÷®fSHR 4 @t¬ B÷ WKY ¥}> ifÞ}BWKY ·®I SHR¤J(5)f +] (hPTH)¬ XB¬(6)fÞ}B !`aßqà R hPTHSHRJ¿!"def #Y#$ %& $>%YÉ&'ubc ? SHR 1 WKY 5 @¹B ? ()¦§¨©f*+D,Út ? B{-,zfWKY ? 10 @LB(.*>/B ? »01SHR u¥»2 ? f20 @LBSHR .* ? 9'f 10-25 @:»s@t; ? SHR ¦§st WKY ? vwf hPTH 14 - ? SHR (Éj SHR JrB)¦§¨©f ? WKY u&'B§,st ? ; SHR &'f hPTH ? SHR &'B{rj SHR J ? vwf $Ñ%YcÁH< IY= >?@Abc W K Y = ? @ A r SHRByBC7z¨©f hPTH : SHR J=?@ AÉj SHR rBD) ¦§¨©fWKY > ?@AÉ SHR rBD)¦§ bcf : SHR J>?@ A¦§j SHR Jf IIYE>FGAbc WKY ¼E>FG É SHR HrB)¦§bcf : SHR JE>FG A WKY J j SHRJf¢I 8 Z 16 [\ hPTH JBBC7zJKf I I IYLM NFOAbc W K Y LMAÉ SHR rBDj¦§bcf : SHR JLMA¦ § WKY J j SHR Jf¢:JBNFOADj ¦§¨©f (# ) Y k P § [ Q PR!SuH< SHR É WKY qX rB¦§if HV
qXÉj SHR JrB ¦§deByD WXB÷âTUf (V)YmnopWX:Ábc IY WXWKY : SHR J§,j SHR Jf IIYWXYZWKY : SHRJ¦§ j SHR Jf IIIYWKY : SHR J¦§âj SHR Jf IVY[\W¯°WKY : SHRJ¦§j SHR Jf (])Ymnop:Ábc IY23WWKY : SHRJ¦§â j SHR Jf IIY 23W WKY ¦§â SHRfL 4 Z 8 [ \ hPTH SHR JB¦§ j SHR Jf 16 [ \ JÉj SHR J rB¥)¦§¨©f IIIY 1u SHR ¦§ WKY fj SHR JB{ hPTH : SHR Jf IVY ^_WKY ¦§ SHRfL 4 Z 8 [ \ hPTH SHR JB¦§ j SHR Jf 16 \ SHR JÉj SHR JrB¥)C7z¨©f VY WKY ¦§ SHRfL 4 Z 8 [ \ hPTH SHR J¦§ j SHR Jf 16 [ \ SHR JÉj SHR JrB¥)C7z¨©f $`%YmnopaÀÁbc IY HWKY ¦§ SHRfL hPTH : SHR J ¦§j SHR JBy DWX÷TUf IIY WKY ¦ § SHRfL hPTH : SHR J¦§j SHR JfL 16 [\ hPTH J Ibâf IIIY:JcjB C7z¨©f IVY WKY ¦§x SHRfL hPTH : SHRJx¤JByDWX B÷TUf (d)YmnopÀÁbc qefg¯°Y hijkBhijkH1 ®¯°B WKY ¦§ SHRf÷L hPTH : SHR JB¦§j SHR JB yDWXB÷if VY%& ? SHR 21 @¼B=?@1>? @Arst WKY ¤Jxf}g hÉ Bindels l 1987 Úmngh os(7)fTU hPTH B>? @Af}p·ÎÉq>? @Zrs>?@' ±²(8)Ïf E>FGAB·t±
ÍÎuj(marker)fAD, Ê÷By ÉHc®Ï(9)f hPTH v SHR JB¼E>FG¦§ BI Ê ðw>xyzf ¼LM NFOAÆrÍ ÎujBr SHR É WKY {JD )¦§bcf}ghÉ McCarron l+ ios(10)fLå&|}~FB rM±²Buj·ñ rÍÎ(11)fÞ}B hPTH B¼LMA÷NF D)SbcB·ÎåÍΩZå &| ÆÇ±²³f SHR mnoGpq XB¦§iB÷ hPTH v 14 -BXܦ§± ²fghÉ ®X(12) ßqàH(13) l hPTH B¬q Xghå>³f SHR ® Î (bone-forming activity) WKY ¤JxB}ghÉ, -.l(14) 26 @ SHR mJ¿ oif hPTH v 14 - SHRJB®Îcjkl hPTH v SHR JvwByDWX TUf}p¦ hPTH ¬Ë Ì9(osteo-progenitor cells) Hc±²(15)f hPTH vB o ÏÁBjkl hPTH v SHR J1 SHR+16Ðg hPTH JÉj SHR J)¦§¨©f¾}«B »sWX hPTH ¬Ä» s±²ByrxWX(SHR+4 or 8Ðg ÍÎB÷rWX (SHR+16Ðg hPTH )~B¬k ÍÎf hPTH v SHR JB aÀÁbcghÉGunnessl(16) ² hPTH v ghofhPTH ¬´ g0rB*åLfg QRqXBs~{¬´ W (biomechanical competence)f hPTH v SHR JBe fg¯°¦§jkl hPTH SHR Jf}ghÉ B hPTH B·Lie fg¯°i(12)of}p ¦ hPTH ®±²f '()*$+ , &~B×vB:x ÁuX±BòCH< ¡ BL³gh ¢£f !®h¤B 7¥Á¦§(B·ÉL Y|H¨ ©J¿loÏ57ª« zf '-./ 1.ÒÓ4ÔÕôõÓ479 Ú 80 Ú+ Ö¬B&®8 ¯:°±¬+ ²³v#´B1992f
2.Consensus Development Conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94: 646- 650,1993.
3.Wang, T.M. : Report of 4th International Convention of Osteoporosis. Science Development, Monthyl, NSC, ROC
4.Okamoto K and Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27:282-293, 1963. 5.Yamori Y.: Handbook of Hypertension :
Experimental and Genetic Models of Hypertension. Elsevier Science Publishers BV, 1984.
6.Moseki L, Sogaard CH, Danielsen CC, Torring O and Nilsson MHL: The anabolic effects of hPTH on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing : a comparison study between hPTH-(1-34) and -(1-84). Endocrinology 129:421-428, 1991. 7.Bindels RJM, Brock LAM, Jongen MJM,
Hackeng WHL and Lowik WJM: Increased plasma calcitonin levels in young spontaneously hypertensive rats: Role in disturbed phosphate homeostasis. Pflugers Arch. 408: 395-400, 1987. 8.Bindels RJM, Geertsen JA and Os CH:
Increased transport of inorganic phos-phate in renal brush broders of spontaneously hypertensive rats. Am.J. physiol. 250: F470-F475, 1986.
9.Hanazawa S, Ohmori Y, Amano S, Hirose K, and Kitano S: Human purified interleukin-1 inhibits DNA synthesis and cell growth of osteoblastic cell line, but enhance alkaline phosphatase activity in the cells, FEBS Letters 203: 279-284, 1986.
10.McCarron D, Yung NN, Ugoretz BA and Krutzik S: Disturbances of calcium m e t a b o l i s m i n the spontaneously hypertensive rat : Attenuation of hyper- tension by calcium supplementation.
Hypertension 43: 1162-1167, 1981. 11.Stern N, Lee DBN, Silis V, Beck FWJ, Deftos L and Sowers JR : Effects of high calcium intake on blood pressure and calcium intake on blood pressure and calcium metabolism metabolism in
young SHR. Hypertension 6: 639-646, 1984.
12.Gasser JA and Jerome CP: Parathyroid hormone : a cure for osteoporosis? Triangle 31: 111-121, 1992.
13.Reeve J, Williams D, Hesp R, Hulme P, Kleneman L, Zanelli JM and Parsons
JA : Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1:1035-1038, 1976.
14.Wang TM, Hsu JF, Jee WSS and Matthews JL : Evidence for reduced c a n c e l l o u s b o n e m a s s i n t h e spontaneously hypertensive rat. Bone
Miner. 20:251-264, 1993.
15.Owen M: Cellular dynamics of bone. In: Bourne GH (ed) The biochemistry and physiology of bone, 2nd ed., Vol.3. Academic Press, New York, 1971, pp. 271-298.
16.Gunness M and Hock JM: Anabolic effect of parathyroid hormone on cancellous and cortical bone histology.
Bone 14: 277-281, 1993.
?